• Company
• Pharma, Biotech had outstanding export performance last year
• by Kim, Jin-Gu Apr 15, 2024 06:06am

• Company
• Samsung Bioepis’s Stelara biosimilar Epyztek is approved
• by Son, Hyung-Min Apr 15, 2024 06:06am

• Company
• Interleukin inhibitors approved for palmoplantar pustulosis
• by Eo, Yun-Ho Apr 15, 2024 06:06am

• InterView
• 'BMS will invest in and improve access to new drugs in KOR'
• by Eo, Yun-Ho Apr 15, 2024 06:06am

• Company
• MSD Korea’s sales 7%↓ due to the transfer of Januvia sales
• by Son, Hyung-Min Apr 15, 2024 06:05am

• Company
• Boryung actively pursues co-promotion deals…
• by Kim, Jin-Gu Apr 12, 2024 05:41am

• Product
• ‘Wholesale inventory of 110 antitumor drugs at its lowest'
• by Kang, Hye-Kyung Apr 12, 2024 05:41am

• Company
• ‘Mounjaro may shift the Type 2 diabetes treatment paradigm'
• by Son, Hyung-Min Apr 12, 2024 05:41am

• Opinion
• [Reporter’s View] Additions to the post-management system
• by Eo, Yun-Ho Apr 12, 2024 05:41am

• Policy
• Reimb price of Forxiga generics fluctuates amid changes
• by Lee, Tak-Sun Apr 12, 2024 05:41am